Antithrombotic regulation in human endothelial cells by fibrinolytic factors

被引:15
作者
Fukao, H [1 ]
Matsuo, O [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Physiol, Osakasayama 5898511, Japan
关键词
endothelial cells; t-PA receptor; u-PA receptor; type 1 plasminogen activator inhibitor; antithrombotic activity;
D O I
10.1055/s-2000-9800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial cells (ECs) modulate the blood fibrinolytic system by secreting tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), and their inhibitor, type-1 plasminogen activator inhibitor (PAI-1), ECs also express t-PA receptors (t-PAR) and u-PA receptors (u-PAR) on their cell surfaces, assembling both enzymes to regulate the cellular fibrinolytic activity. In addition, ECs modulate these factors in response to several stimuli. Fibrin clots on ECs induce the up- and downregulation of t-PA and PAI-1 production, respectively, thus causing an effective lysis of the fibrin clot. Heat shock (43 degrees C) increases the expression of u-PA, t-PA, PAI-1, and u-PAR by which ECs become more fibrinolytic around the cells. Furthermore, because ECs possess t-PAR and u-PAR on their cell surfaces, the binding of t-PA and u-PA is a critical event, which affords ECs the localized and condensed fibrinolytic potential. Therefore, ECs play a central role in antithrombotic activity by regulating the levels of these fibrinolytic factors.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 24 条
[1]   INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 BIOSYNTHESIS BY HYPERTHERMIA [J].
BERGONZELLI, GE ;
KRUITHOF, EKO .
JOURNAL OF CELLULAR PHYSIOLOGY, 1991, 148 (02) :306-313
[2]   THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION [J].
DANO, K ;
BEHRENDT, N ;
BRUNNER, N ;
ELLIS, V ;
PLOUG, M ;
PYKE, C .
FIBRINOLYSIS, 1994, 8 :189-203
[3]  
Fukao H, 1996, THROMB HAEMOSTASIS, V75, P352
[4]   Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells [J].
Fukao, H ;
Ueshima, S ;
Takaishi, T ;
Okada, K ;
Matsuo, O .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1356 (01) :111-120
[5]   ANALYSIS OF BINDING-PROTEIN FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN ENDOTHELIAL-CELLS [J].
FUKAO, H ;
HAGIYA, Y ;
NONAKA, T ;
OKADA, K ;
MATSUO, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) :956-962
[6]   EFFECTS OF FIBRIN ON THE SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FROM ENDOTHELIAL-CELLS AND ON PROTEIN-KINASE-C [J].
FUKAO, H ;
MATSUMOTO, H ;
UESHIMA, S ;
OKADA, K ;
MATSUO, O .
LIFE SCIENCES, 1995, 57 (13) :1267-1276
[7]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR, TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND THEIR COMPLEX IN PLASMA WITH DISSEMINATED INTRAVASCULAR COAGULATION [J].
FUKAO, H ;
UESHIMA, S ;
OKADA, K ;
YAMAMOTO, K ;
MATSUO, T ;
MATSUO, O .
THROMBOSIS RESEARCH, 1992, 68 (01) :57-65
[8]   The role of the pericellular fibrinolytic system in angiogenesis [J].
Fukao, H ;
Ueshima, S ;
Okada, K ;
Matsuo, O .
JAPANESE JOURNAL OF PHYSIOLOGY, 1997, 47 (02) :161-171
[9]  
FUKAO H, 1990, THROMB RES S10, V57, P11
[10]  
HAJJAR KA, 1994, J BIOL CHEM, V269, P21191